UBS Group’s CM Life Sciences Inc Unit CMLFU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-1,030
Closed -$16K – 10769
2021
Q2
$16K Sell
1,030
-646
-39% -$9.34K ﹤0.01% 7622
2021
Q1
$28K Sell
1,676
-12,063
-88% -$212K ﹤0.01% 7084
2020
Q4
$159K Buy
+13,739
New +$148K ﹤0.01% 5386

UBS Group's CMLFU Position: Q3 2021 in Review

UBS Group sold out of CM Life Sciences Inc Unit (CMLFU) in Q3 2021, closing a stake of 1,030 shares — an estimated $16K sold.

UBS Group first reported a position in CMLFU in Q4 2020 and held it in 3 quarters. The position peaked at $159K in Q4 2020. 0 funds tracked by Wall St. Rank hold CMLFU as of Q3 2021.

  • UBS Group reported no remaining CM Life Sciences Inc Unit position as of Q3 2021 after selling out during the quarter.
  • UBS Group sold 1,030 CM Life Sciences Inc Unit shares in Q3 2021, an estimated $16K.
  • UBS Group first reported a position in CM Life Sciences Inc Unit in Q4 2020 and held it in 3 quarters.
  • UBS Group's CM Life Sciences Inc Unit position peaked at $159K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held CM Life Sciences Inc Unit as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.